Clinical Trials on Complicated Urinary Tract Infections in Australia

Total 2323 results

Green Beat
Medical University of Graz

Completed

Micronutrient Supplementation and Incidence of Common Cold

Immune System Diseases

Austria
The University of Western Australia

Completed

Optimisation of the Management of Placental Delivery in Second Trimester Pregnancy Interruption

Postpartum Hemorrhage | Placenta, Retained

Australia
Inimmune Corporation
Avance Clinical Pty Ltd.

Recruiting

Trial of INI-2004 in Healthy Volunteers and Participants With Allergic Rhinitis.

Allergic Rhinitis | Allergic Rhinitis Due to Weed Pollen

Australia
Dompé Farmaceutici S.p.A

Recruiting

Reparixin add-on Therapy to Std Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia

Severe COVID-19 | Infectious Pneumonia

United States, Australia, Turkey, Argentina, Germany, Austria, Italy
Moritz Oberndorfer
Merck Gesellschaft mbH, Austria

Completed

Lipid Profile and Diabetes Mellitus in People With HIV

HIV Infections | Diabetes Mellitus | Dyslipidemias | Cardiovascular Risk Factor

Austria
Medical University of Vienna

Recruiting

HRQOL of Life After ECMO Due to COVID-19.

Extracorporeal Membrane Oxygenation | ARDS | COVID-19 Pneumonia

Austria
Novartis Pharmaceuticals

Terminated

Everolimus Post Pazopanib Treatment in Metastatic or Advanced Renal Cell Carcinoma (CATChEz)

Carcinoma, Renal Cell

Australia, Korea, Republic of
Gilead Sciences

Recruiting

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen (ARTISTRY-1)

HIV-1-infection

Japan, Germany, France, United States, Spain, Korea, Republic of, South Africa, Australia, Argentina, Canada, Dominican Republic, Italy, Puerto Rico, Taiwan, United Kingdom
Ology Bioservices

Completed

Adult Safety Study of 2009/2010 Seasonal Influenza Vaccine

Influenza

Austria, Belgium
Medical University of Vienna

Completed

COVID-19 Testing in Patients With Vascular Disorders

Covid19

Austria
Medical University Innsbruck
Boehringer Ingelheim

Unknown

Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19) (CovILD)

Covid-19 | Pulmonary Fibrosis

Austria
Ology Bioservices

Completed

Phase 3 Immunogenicity and Safety Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)

Influenza

Germany, Austria
EyeGene Inc.
Novotech (Australia) Pty Limited

Active, not recruiting

Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-COVID and EG-COVARo in Healthy Adult Volunteers

COVID-19 Vaccine

Australia
Sir Charles Gairdner Hospital

Completed

Effect of 25-hydroxyvitamin D and a Structured Exercise Program on Dialysis Patients

End Stage Kidney Disease

Australia
University of Minnesota
National Health and Medical Research Council, Australia; Bristol-Myers Squibb; National Institutes of Health Clinical Center (CC) and other collaborators

Completed

Strategic Timing of Antiretroviral Treatment (START)

HIV Infection

Spain, United States, United Kingdom, Ireland, Australia, Argentina, Denmark, Sweden, Israel, Switzerland, Germany, Brazil, Norway, Chile, Thailand, Peru, Portugal, Greece, Luxembourg, Uganda, Austria, Belgium, Czechia, Estonia, Finland, ... and more
University of Alberta
Princess Alexandra Hospital, Brisbane, Australia; Austin Hospital, Melbourne...

Terminated

Furosemide in Early Acute Kidney Injury (SPARK)

Acute Renal Failure

Australia, Canada
Medical University of Vienna

Completed

Evaluation of Innovative Tools in Development of Antibiotics

Pneumonia

Austria
Sir Charles Gairdner Hospital

Completed

Short Term Effects of FX Dialysers on QOL and Inflammation

Kidney Failure, Chronic

Australia
Vienna Hospital Association

Recruiting

Non-invasive Nervus Vagus Stimulation in Patients With COVID-19 and ARDS

COVID-19 | ARDS | Cytokine Storm

Austria
Melbourne Health

Terminated

Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Kidney Failure.

Renal Failure

Australia
The University of Queensland
Tan Tock Seng Hospital; University of North Carolina, Chapel Hill; Royal Brisbane... and other collaborators

Completed

Risks of Bacterial and Fungal Superinfection in Patients With COVID-19

COVID-19

Thailand, United States, Australia, Singapore, India
Brii Biosciences Limited

Completed

A Study of BRII-297 in Healthy Adult Subjects

Postpartum Depression

Australia
Merck Sharp & Dohme LLC

Completed

Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)

Cervical Cancer | Vulvar Cancer | Vaginal Cancer | Human Papillomavirus Infection | Genital Warts

Austria, Belgium, Finland, Germany, Italy, Spain
Community and Patient Preference Research Pty Ltd
Seqirus Limited; Glenmark Pharmaceuticals

Withdrawn

Impact of RYALTRIS® Nasal Spray on Patients' Reported Outcomes

Allergic Rhinitis

Australia
GlaxoSmithKline

Completed

Repeat Dose Safety Study for Compound to Treat Anemia

Kidney Disease

Australia
GlaxoSmithKline

Completed

Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects

Prophylaxis for Herpes Simplex

Austria, Germany, Belgium, United States, Australia, Canada, Denmark, France, Puerto Rico, South Africa, Spain, Switzerland
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Quadrivalent Influenza Vaccine Administered Intramuscularly in Children/Adolescents and Adults

Influenza

Australia, Philippines
BioNTech SE
Pfizer

Completed

Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age

COVID-19 | SARS-CoV-2 Infection

Australia, New Zealand
Bayside Health
University of Melbourne

Completed

Prevalence and Treatment of Urinary Incontinence in Women With Cystic Fibrosis and Chronic Obstructive Pulmonary Disease

Cystic Fibrosis | Chronic Obstructive Pulmonary Disease (COPD)

Australia
Novartis Vaccines
Department of Health and Human Services

Completed

Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects

Pandemic H5N1 Influenza

United States, Australia, New Zealand, Thailand
Clarity Pharmaceuticals Ltd

Completed

Positron Emission Tomography (PET) Imaging of Participants With Confirmed Prostate Cancer Using 64Cu-SAR-bisPSMA (PROPELLER) (PROPELLER)

Prostatic Neoplasms

Australia
Pfizer

Completed

Safety and Immunogenicity of RSVpreF Coadministered With SIIV in Adults ≥65 Years of Age

Respiratory Syncytial Virus

Australia
The University of Western Australia
King Edward Memorial Hospital

Completed

The Cycle Study: a Study of the Effectiveness of Cycling Exercise in Breaking the Cycle of Pregnancy Diabetes

Gestational Diabetes Mellitus

Australia
Lyra Therapeutics

Completed

480 Biomedical Sinus Drug Depot

Chronic Sinusitis

New Zealand, Australia
Glaxo Wellcome

Completed

The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-Dideoxyinosine or 2',3'-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease

HIV Infections

United States, Puerto Rico, Australia
Medical University of Graz

Completed

ICU Trial in Critical Ill COVID-19 Patients (POINT-C)

Critical Illness | Covid19 | Risk Factor, Cardiovascular | Course Illness

Austria
Kirby Institute
The University of New South Wales

Terminated

Toxicity Substudy of Evaluation of Subcutaneous Proleukin in a Randomised International Trial (ESPRIT): TOXIL-2 Substudy

HIV Infections

Argentina, Israel, Australia
Arduino Mangoni

Completed

Mechanisms of Anti-VEGF Induced Hypertension

Renal Cancer

Australia
Medical University of Vienna
Campus Bio-Medico University

Recruiting

Transcranial Pulse Stimulation (TPS) in Post-COVID-19

Fatigue | Post-COVID-19 Syndrome

Austria, Italy
Medical University of Graz
Medical University Innsbruck; Austrian Science Fund (FWF); AGES

Completed

Severe Acute Respiratory Syndrome Coronavirus 2 Re-Infection Risk and Vaccine Efficacy in Austria (SARIVA)

COVID-19

Austria
Baker Heart and Diabetes Institute

Terminated

Renal Denervation for Complicated Hypertension (RDNP-2012-03)

Hypertension

Australia
DualityBio Inc.

Recruiting

A Study of DB-1311 in Advanced/Metastatic Solid Tumors

Advanced Solid Tumors

United States, Australia
Medical University Innsbruck

Not yet recruiting

Olfactory Training in COVID-19 Associated Loss of Smell

COVID-19 | Hyposmia

Austria
Austin Health

Completed

Catecholamine-O-Methyl-Transferase(COMT)-Polymorphism in Cardiac Surgery

Cardiac Surgery

Australia
Neutrolis

Terminated

Phase 1 Study to Assess Safety, Tolerability, PD, PK, Immunogenicity of IV NTR-441 Solution in Healthy Volunteers and COVID-19 Patients

Covid19

Austria, Ukraine
Pfizer

Completed

Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age

COVID-19 | SARS-CoV-2 Infection

Australia, New Zealand
Ology Bioservices

Completed

Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Whole Virion, Vero Cell Derived)

Influenza

Germany, Austria
Ology Bioservices

Completed

Comparison of the Safety and Immune Response of Three Different Lots of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2004/2005

Influenza

Austria, Germany
GlaxoSmithKline

Completed

A Relative Bioavailability Study of Fluticasone Furoate and Levocabastine

Rhinitis, Allergic, Perennial and Seasonal

Australia
Novartis Pharmaceuticals

Terminated

Adjuvant Docetaxel-Zoledronic Acid in High-risk Early Prostate Cancer Following Prostatectomy.

Prostate Cancer

Australia

Clinical Trials on Complicated Urinary Tract Infections in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations